สืบเนื่องจากคำถามของลูกค้า แผนก PV

สืบเนื่องจากคำถามของลูกค้า แผนก PV ไม่เคยได้รับข้อมูลการรรายงานความปลอดภัยของ dextran ที่ผลิตโดยบริษัทของเรา
อย่างไรก็ตาม เมื่อได้ทำการค้นข้อมูลเพิ่มเติมในเรื่องการตกตะกอนของ dextran 40 นั้นพบว่ามีรายงานการเกิดขึ้นได้ อ้างอิงจากรายงานของ Hospira Medical Communications (แหล่งข้อมูลเดียวกันกันกับลิงค์ในข้อ 3ที่ลูกค้าส่งมาให้) และจากคำแนะนำในการใช้ Low Molecular Weight Dextran for Intravenous Administration นั้น มีคำแนะนำว่า Do not use if crystallization has occurred และ When infusing concentrated LMD, the administration set should include a filter เกี่ยวกับคำแนะนำ เกี่ยวกับกับการใช้ filter นั้นแนะนำให้ใช้ ขนาด 0.22 micron filter
http://www.hospira.com/Images/DHP%20Event%204414%20FA309-08%20Final5_81-92087_1.pdf
Dianne L. Josephson. Intravenous Infusion Therapy for Nurses: Principles & Practice. (2009) p.431

สำหรับชนิดหรือประเภทของ Infusion Set นั้น ไม่ได้กล่าวถึงอย่างเฉพาะเจาะจง

ผลลัพธ์ (อังกฤษ) 1:

Because the customer's questions, the Department had never received completion of PV to raraingan the safety of dextran produced by our company.However, When you have additional information regarding the settling of dextran 40. finds that there has been reported to occur. References from reports of Hospira Medical Communications (data source, same with the links in the customer sends to 3) and the recommendation on the use of Low Molecular Weight Dextran for Intravenous Administration is not advice that Do use has occurred and if crystallization When the administration concentrated LMD, infusing set a filter should include instructions about using the recommended filter size 0.22 micron filter.http://www.hospira.com/Images/DHP%20Event%204414%20FA309-08%20Final5_81-92087_1.pdfDianne L. Josephson. Intravenous Infusion Therapy for Nurses: Principles & Practice. (2009) p.431For the type or types of Infusion Set is not discussed specific.

ผลลัพธ์ (อังกฤษ) 2:

Due to customer questions PV department had not received information on the safety report of dextran produced by our company
, however. When the additional information is located in the precipitation of dextran 40 were found to have been reported to occur. According to reports, Hospira Medical Communications. (Same source as the link above. 3. The client sent) and the instructions on the use of Low Molecular Weight Dextran for Intravenous Administration has recommended that the Do not use if crystallization has occurred and When infusing concentrated LMD, the administration set should include a filter on the instructions. About the use of the recommended filter size 0.22 Micron Filter
Http://www.hospira.com/Images/DHP%20Event%204414%20FA309-08%20Final5_81-92087_1.pdf
Dianne L. Josephson. Intravenous Infusion Therapy for. Nurses: Principles & Practice. (2009) p.431 for the type or types of Infusion Set is not mentioned specifically.

ผลลัพธ์ (อังกฤษ) 3:

According to customer's question, Department PV never get information to report the safety of dextran that produced our company
.However, when the search more information about precipitation of dextran 40 that had reported occur. Based on report. Hospira Medical Communications (same source with link in an 3 customer sent).Low Molecular Weight Dextran for Intravenous Administration, suggest that Do not use if crystallization has occurred. When infusing concentrated, and LMDThe administration set should include a filter about the suggestion about using that filter recommended size 0.22 micron. Filter
http: / / www.hospira.com / Images / DHP%20Event%204414%20FA309-08%20Final5_81-92087_1.pdf
Dianne L. Josephson. Intravenous. Infusion Therapy for Nurses: Principles & Practice. (2009) p.431

.For the type or types of Infusion Set is not mentioned specifically
.